The U.S. medical device market is regulated by the Center for Devices and Radiological Health (CDRH), part of the FDA. Learn more about the CDRH.
Devices in the U.S. are classified based on risk :
Four major steps to market :
Defined in 21 CFR 822, including surveillance under section 522 of the FD&C Act. Guidance for Post-market Surveillance.
Mandates UDI labeling and data submission in the GUDID Unique Device Identification System and Policy Regarding Compliance Dates.
The FDA encourages using FDA-recognized consensus standards in premarket submissions. Standards and Conformity Assessment Program.
Fees for 2024 include establishment registration, 510(k), PMA, De Novo Classification Request, and annual fees for periodic reporting on class III devices. Who Must Register, List, and Pay the Fee and Reduced Medical Device User Fees for Small Businesses.
At Medfins International, we are dedicated to guiding you through the complexities of the U.S. medical device market. Our experts are proficient in FDA regulations and offer comprehensive support at every stage, from device classification to market authorization and post-market requirements.
To learn more about the U.S. FDA regulatory market and how Medfins International can support your business, book a free consultation with our FDA regulatory experts. Our team is ready to guide you through every aspect of the FDA regulatory process, guaranteeing a seamless experience in the U.S. medical device market.